001     148331
005     20240229123031.0
024 7 _ |a 10.1002/ijc.32415
|2 doi
024 7 _ |a pmid:31107546
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:60752705
|2 altmetric
037 _ _ |a DKFZ-2019-02887
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Obón-Santacana, Mireia
|0 0000-0003-4646-3513
|b 0
245 _ _ |a Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a Bognor Regis
|c 2020
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1575881283_16294
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country-specific dietary questionnaires. After a mean follow-up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72-1.10; p-trend = 0.70). Furthermore, no evidence for effect-measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Luján-Barroso, Leila
|b 1
700 1 _ |a Freisling, Heinz
|b 2
700 1 _ |a Naudin, Sabine
|b 3
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 4
700 1 _ |a Mancini, Francesca Romana
|0 0000-0003-2297-3869
|b 5
700 1 _ |a Rebours, Vinciane
|b 6
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 7
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 8
|u dkfz
700 1 _ |a Boeing, Heiner
|b 9
700 1 _ |a Tjønneland, Anne
|b 10
700 1 _ |a Olsen, Anja
|b 11
700 1 _ |a Overvad, Kim
|b 12
700 1 _ |a Lasheras, Cristina
|b 13
700 1 _ |a Rodríguez-Barranco, Miguel
|b 14
700 1 _ |a Amiano, Pilar
|b 15
700 1 _ |a Santiuste, Carmen
|b 16
700 1 _ |a Ardanaz, Eva
|b 17
700 1 _ |a Khaw, Kay-Thee
|b 18
700 1 _ |a Wareham, Nicholas J
|b 19
700 1 _ |a Schmidt, Julie A
|0 0000-0002-7733-8750
|b 20
700 1 _ |a Aune, Dagfinn
|b 21
700 1 _ |a Trichopoulou, Antonia
|b 22
700 1 _ |a Thriskos, Paschalis
|b 23
700 1 _ |a Peppa, Eleni
|b 24
700 1 _ |a Masala, Giovanna
|b 25
700 1 _ |a Grioni, Sara
|b 26
700 1 _ |a Tumino, Rosario
|b 27
700 1 _ |a Panico, Salvatore
|b 28
700 1 _ |a Bueno-de-Mesquita, Bas
|b 29
700 1 _ |a Sciannameo, Veronica
|b 30
700 1 _ |a Vermeulen, Roel
|b 31
700 1 _ |a Sonestedt, Emily
|b 32
700 1 _ |a Sund, Malin
|b 33
700 1 _ |a Weiderpass, Elisabete
|b 34
700 1 _ |a Skeie, Guri
|b 35
700 1 _ |a González, Carlos A
|b 36
700 1 _ |a Riboli, Elio
|b 37
700 1 _ |a Duell, Eric J
|0 0000-0001-5256-0163
|b 38
773 _ _ |a 10.1002/ijc.32415
|g Vol. 146, no. 1, p. 76 - 84
|0 PERI:(DE-600)1474822-8
|n 1
|p 76 - 84
|t International journal of cancer
|v 146
|y 2020
|x 1097-0215
909 C O |o oai:inrepo02.dkfz.de:148331
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21